Inflammatory markers in COPD

被引:37
|
作者
Larsson, K. [1 ]
机构
[1] Karolinska Inst, Natl Inst Environm Med, Unit Lung & Allergy Res, SE-17177 Stockholm, Sweden
关键词
chemokines; COPD; inflammation; markers; neutrophils;
D O I
10.1111/j.1752-699X.2008.00089.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) is identified as all inflammatory disorder characterised by airway and lung inflammation and destruction with systemic involvement of multiple organ systems. The inflammatory reaction could be monitored not only in the airways by the use of bronchoalveolar lavage (BA-L), sputum, exhaled air, and exhaled breath condensate but also in blood and Urine as well as in tissue obtained at surgery or autopsy. There is a large number of cytokines, chemoattractants and other mediators that are of importance for the interplay of inflammatory mechanisms in COPD. Neutrophilic granulocytes are key players in the inflammatory reaction and the most important chemoattractants for these cells seem to be IL-8 (CXCL8) and leukotriene B-4 (LTB4). Also, the macrophages and chemoattractants for mononuclear cells (CCL2, CCL3) are of importance as are T-lymphocytes, predominantly of the cytotoxic Subtype (CD8+). Analyses in exhaled breath condensates and exhaled air have not been tremendously encouraging but there is a clear space for further development in this field within the near future. Blood markers, such as IL-6, CRP, and fibrinogen, have attracted interest during recent years, and further studies in this area will probably increase the understanding of systemic manifestations in COPD, in particular, regarding co-morbidity with cardiovascular disease.
引用
收藏
页码:84 / 87
页数:4
相关论文
共 50 条
  • [41] The evaluation of inflammatory, anti-inflammatory and regulatory factors contributing to the pathogenesis of COPD in airways
    Vitenberga, Zane
    Pilmane, Mara
    Babjoniseva, Aurika
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (01) : 97 - 105
  • [42] An audit of inpatient mortality and readmission rates in acute exacerbation of COPD - Exploring the role of comorbidity and inflammatory markers
    McClintock-Tiongco, Aisha
    Patel, Arjun
    Chakravorty, Indranil
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [43] Plasma levels of myokines and inflammatory markers are related with functional and respiratory performance in older adults with COPD and sarcopenia
    da Silva Lage, Vanessa Kelly
    de Paula, Fabiana Angelica
    Lima, Liliana Pereira
    Vitor Santos, Joyce Noelly
    dos Santos, Jousielle Marcia
    Viegas, Angela Alves
    da Silva, Guilherme Pinto
    de Almeida, Hellen Cristina
    Nunes Teixeira Rodrigues, Ana Luiza da Silva
    Oliveira Leopoldino, Amanda Aparecida
    Pereira de Avelar, Nubia Carelli
    Danielewicz, Ana Lucia
    Parentoni, Adriana Netto
    Teixeira, Antonio Lucio
    Oliveira, Murilo Xavier
    Rodrigues Lacerda, Ana Cristina
    Mendonca, Vanessa Amaral
    EXPERIMENTAL GERONTOLOGY, 2022, 164
  • [44] Inflammatory markers in skeletal muscle of older adults
    Caldow, Marissa K.
    Cameron-Smith, David
    Levinger, Pazit
    McKenna, Michael J.
    Levinger, Itamar
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2013, 113 (02) : 509 - 517
  • [45] Inflammatory Markers in Anorexia Nervosa: An Exploratory Study
    Dalton, Bethan
    Campbell, Iain C.
    Chung, Raymond
    Breen, Gerome
    Schmidt, Ulrike
    Himmerich, Hubertus
    NUTRIENTS, 2018, 10 (11)
  • [46] Involvement of inflammatory markers in pathogenesis of venous thromboembolism
    Cocoi, Alexandra Florina
    Pop, Dana
    Cocoi, Mihai
    Serban, Adela Mihaela
    Vida-Simiti, Luminita Animarie
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2017, 25 (03): : 227 - 236
  • [47] Role of inflammatory biomarkers in COPD
    Alkady, Ola
    Fattouh, Mona
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [48] The effect of azithromycin on sputum inflammatory markers in bronchiectasis
    Terpstra, L. C.
    Altenburg, J.
    Doodeman, H. J.
    Pineros, Y. S. Sabogal
    Lutter, R.
    Heijerman, H. G. M.
    Boersma, W. G.
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [49] Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease
    Breland, Unni M.
    Hollan, Ivana
    Saatvedt, Kjell
    Almdahl, Sven M.
    Damas, Jan K.
    Yndestad, Arne
    Mikkelsen, Knut
    Forre, Oystein T.
    Aukrust, Pal
    Ueland, Thor
    RHEUMATOLOGY, 2010, 49 (06) : 1118 - 1127
  • [50] Autoimmune induction of a COPD-like inflammatory phenotype in mice
    Baumgartl, Nadja
    Garn, Holger
    Turowska, Agnieszka
    Weissmann, Norbert
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42